Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CFMS

Conformis (CFMS) Stock Price, News & Analysis

Conformis logo

About Conformis Stock (NASDAQ:CFMS)

Advanced Chart

Key Stats

Today's Range
$2.25
$2.27
50-Day Range
$2.22
$2.26
52-Week Range
$1.05
$7.25
Volume
7,000 shs
Average Volume
99,585 shs
Market Capitalization
$17.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CFMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conformis and its competitors with MarketBeat's FREE daily newsletter.

CFMS Stock News Headlines

Conformis (NASDAQ: CFMS)
Trump’s $100 Trillion Land Rush Is On
What Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trillions in oil, gas, lithium, and land rights. Whitney Tilson breaks it all down, and shows how everyday Americans can grab a stake. His urgent new briefing explains "The US: IPO"... and how to get in before the looming federal deadline.
CFM Investment JSC CFM
Computer Forms (Malaysia) Bhd (CFMS)
Durham medtech completes acquisition of public company
See More Headlines

CFMS Stock Analysis - Frequently Asked Questions

Conformis, Inc. (NASDAQ:CFMS) announced its quarterly earnings data on Wednesday, November, 3rd. The medical instruments supplier reported ($1.75) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($1.75). The medical instruments supplier earned $14.25 million during the quarter, compared to analysts' expectations of $14.08 million. Conformis had a negative net margin of 72.72% and a negative trailing twelve-month return on equity of 86.46%.
Read the conference call transcript
.

Conformis's stock reverse split before market open on Wednesday, November 9th 2022.The 1-25 reverse split was announced on Wednesday, November 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Conformis (CFMS) raised $135 million in an IPO on Wednesday, July 1st 2015. The company issued 9,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Conformis investors own include Meta Platforms (META), Micron Technology (MU), NIO (NIO), NVIDIA (NVDA), Alibaba Group (BABA), QUALCOMM (QCOM) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/03/2021
Today
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:CFMS
CIK
1305773
Employees
295
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($5.61)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.47 million
Net Margins
-72.72%
Pretax Margin
-72.63%
Return on Equity
-86.46%
Return on Assets
-47.65%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
5.07
Quick Ratio
3.30

Sales & Book Value

Annual Sales
$57.06 million
Price / Sales
0.31
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.07 per share
Price / Book
0.56

Miscellaneous

Outstanding Shares
7,878,000
Free Float
7,579,000
Market Cap
$17.80 million
Optionable
Not Optionable
Beta
1.39

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:CFMS) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners